| Financial Year |
March 31 2023 |
| Monetary Funds |
970,784,945.19 |
| Held-for-trading Financial Assets |
107,178,671.60 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,016,959,380.08 |
| Advances to Suppliers |
168,194,558.94 |
| Other Receivables |
31,894,373.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
937,658,306.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
97,254,750.47 |
| Total Current Assets |
3,329,924,986.41 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
66,835,455.58 |
| Investment Properties |
30,726,095.02 |
| Fixed Assetes |
1,859,947,145.23 |
| Under-construction Projects |
124,233,943.35 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
131,678.68 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
541,257,442.02 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
169,512,897.65 |
| Other Non-Current Assets |
67,852,128.30 |
| Sub-Total of Non-Current Assets |
2,874,687,135.05 |
| Total Assets |
6,204,612,121.46 |
| Short-Term Loans |
709,631,962.75 |
| Trading Financial liabilities |
3,146,453.49 |
| Notes Payable |
645,297,109.49 |
| Accounts Payable |
756,167,134.65 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
45,539,112.26 |
| Taxes Payable |
42,888,668.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
89,046,932.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
228,800.48 |
| Other Current Liabilities |
4,988,901.48 |
| Sub-Total of Current Liabilities |
2,570,357,803.96 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
99,952,255.18 |
| Deferred Income Tax Liabilities |
119,607,886.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
262,150,777.43 |
| Total Liabilities |
2,832,508,581.39 |
| Paid-In Capital(Or Share Stock) |
340,230,446.00 |
| Capital Surplus |
701,209,988.05 |
| Surplus Reserve |
116,416,960.11 |
| LESS:Treasury Stock |
53,456,065.00 |
| Undistributed Profits |
2,227,375,984.29 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,372,103,540.07 |
| Owner's Equity（Stockholder's Equity） |
3,372,103,540.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,204,612,121.46 |
